Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000055784 | SCV000446883 | likely benign | Atypical hemolytic-uremic syndrome with I factor anomaly | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Labcorp Genetics |
RCV000892174 | SCV001036036 | likely benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Cavalleri Lab, |
RCV001171354 | SCV001328301 | likely benign | Chronic kidney disease | 2020-05-28 | criteria provided, single submitter | research | PP3, BP6, BS1 |
Genome Diagnostics Laboratory, |
RCV002294012 | SCV002587674 | likely benign | Atypical hemolytic-uremic syndrome | 2021-01-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496740 | SCV002810046 | likely benign | Atypical hemolytic-uremic syndrome with I factor anomaly; Age related macular degeneration 13; Factor I deficiency | 2022-04-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000892174 | SCV004148684 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | CFI: BP4 |
Breakthrough Genomics, |
RCV000892174 | SCV005263061 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Gene |
RCV000055784 | SCV000086750 | not provided | Atypical hemolytic-uremic syndrome with I factor anomaly | no assertion provided | literature only | ||
Genome Diagnostics Laboratory, |
RCV000892174 | SCV001927386 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000892174 | SCV001952346 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004537251 | SCV004749183 | likely benign | CFI-related disorder | 2023-06-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |